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Background: There is a theoretical concern about reduced efficacy of limus-drug for the treatment of diabetics.
Methods: From the Kobe University OCT data base, 72 lesions (DM: n=27, non-DM: n=45) in 55 patients treated with everolimus-eluting stent 
(EES) that underwent 8-month follow-up OCT were enrolled. In addition to standard variables, variability of neointima thickness (NIT) was evaluated 
by standard deviation of NIT computed from 360 equally-spaced radial sectors along the entire segment. Additionally, the incidence of struts with 
peri-strut low intensity area (%PLIA), suggestive of fibrin deposition or impaired neointima maturation, was calculated.
Results: Despite a greater asymmetric stent expansion in DM (Minimum stent expansion index: DM 0.78±0.06, non DM 0.82±0.06; p=0.041), 
DM showed comparable average NIT (DM: 114±85μm, non DM: 99±49μm; p=0.35) and % uncovered struts (DM: 1.80±4.29, non DM: 1.88±5.96; 
p=0.50) to non-DM. The variability of neointima distribution did not differ between the two groups, suggesting comparably uniform neointimal 
suppression by EES irrespective of DM (DM: 0.076±0.052, non DM: 0.062±0.031; p=0.14). The prevalence of %PLIA didn’t differ between the 
groups (DM:3.1±4.7%, non DM: 1.2±1.7%; p=0.39).
Conclusions: Although a greater asymmetric stent expansion was observed in DM, EES provided similar neointima suppression regardless of DM.
OCT measurement and analysis
Variable
DM
(n=27)
Non DM
(n=45)
P value
Average number of struts (n) 221.9±95.3 200.3±91.7 0.34
% of malapposed stent struts 1.15±3.71 0.50±1.31 0.28
% of uncovered stent struts 1.8±4.3 1.9±6.0 0.95
Average neointimal thickness (μm) 0.11±0.09 0.09±0.05 0.35
Neointima variability score 0.08±0.05 0.06±0.03 0.14
Minimum stent expansion index 0.78±0.06 0.82±0.06 0.04
% peri-strut low intensity area 3.1±4.7 1.2±1.7 0.39
Presence of RUST30 2 4 >0.99
%CS of RUS30 0.06±0.13 0.04±0.12 0.47
